Arca Biopharma buy melinda
Start price
17.09.10
/
50%
€2,005.7
Target price
17.03.11
€3,402.0
Performance (%)
-27.93%
End price
17.03.11
€1,445.5
Summary
This prediction ended on 17.03.11 with a price of €1,445.5. The prediction for Arca Biopharma disappointed with a performance of -27.93%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Arca Biopharma | -1.379% | -1.379% | 53.351% | 7.519% |
iShares Core DAX® | -1.377% | -1.442% | 10.458% | 14.043% |
iShares Nasdaq 100 | 0.827% | -5.117% | 22.834% | 40.300% |
iShares Nikkei 225® | 0.198% | -0.851% | 7.804% | 7.932% |
iShares S&P 500 | 1.364% | -0.887% | 22.672% | 41.522% |
Comments by melinda for this prediction
In the thread Arca Biopharma diskutieren
Pharma
ARCA Biopharma sehr große Spezialist in der Entwicklung und Kommerzialisierung von gentechnisch-spezifischen Therapien (Herzinsuffizienz und anderen Krankheiten)
(Laufzeit überschritten)